Skip to content

Effect of hypertonic saline3% in tramadol toxicity

Evaluation of the effect of hypertonic saline 3%in the treatment of ECG changes and other side effects of tramadol toxicity

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220213054017N1
Enrollment
200
Registered
2022-03-21
Start date
2021-09-23
Completion date
Unknown
Last updated
2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute tramadol toxicity and side effects.

Interventions

Intervention group: For patients with ECG changes 3cc/ kg saline 3% is given and one hour later the amount of ECG changes is checked.

Sponsors

Artesh University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Acute tramadol toxicity Aged over 18 years

Exclusion criteria

Exclusion criteria: Severe disorders such as liver cirrhosis Existence of previous diseases such as dextrocardia or behavioral disorders

Design outcomes

Primary

MeasureTime frame
QRS widening,QT prolongation,RBBB,Tall R,Axis deviation. Timepoint: Before and one hour after treatment with hypertonic saline3%. Method of measurement: ECG.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactEbrahim Karimi

Artesh University of Medical Sciences

Ebrahimkarimi86@ gmail.com009886096350

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026